Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells

Woo Kang Dong, Young Lee Ji, Deuk Hee Oh, Yang Park Seon, Min Woo Tae, Kyoung Kim Mi, Hee Park Mi, Hoon Jang Young, Sik Min Do

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In spite of the importance of phospholipase D (PLD) in cell proliferation and tumorigenesis, little is known about the molecules regulating PLD expression. Thus, identification of small molecules inhibiting PLD expression would be an important advance for PLD-mediated physiology. We examined one such here, denoted "Triptolide", which was identified in a chemical screen for inhibitors of PLD expression using cell assay system based on measurement of PLD promoter activity. Triptolide significantly suppressed the expression of both PLD1 and PLD2 with sub-μM potency in MDA-MB-231 breast cancer cells as analyzed by promoter assay and RT-PCR. Moreover, triptolide abolished the protein level of PLD in a time and dose-dependent manner. Triptolide-induced PLD1 downregulation was also observed in all the cancer cells examined, suggesting a general phenomenon detected in various cancer cells. Decrease of PLD expression by triptolide suppressed both basal and PMA-induced PLD activity. In addition, triptolide inhibited activation of NFκB which increased PLD1 expression. Ultimately, downregulation of PLD by triptolide inhibited proliferation of breast cancer cells. Taken together, we demonstrate that triptolide suppresses the expression of PLD via inhibition of NFκB activation and then decreases cell proliferation.

Original languageEnglish
Pages (from-to)678-685
Number of pages8
JournalExperimental and Molecular Medicine
Volume41
Issue number9
DOIs
Publication statusPublished - 2009 Sep 30

Fingerprint

Phospholipase D
Cells
Breast Neoplasms
Cell proliferation
Assays
triptolide
Down-Regulation
Chemical activation
Cell Proliferation
Molecules
Physiology
Neoplasms
Carcinogenesis

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Dong, Woo Kang ; Ji, Young Lee ; Oh, Deuk Hee ; Seon, Yang Park ; Tae, Min Woo ; Mi, Kyoung Kim ; Mi, Hee Park ; Young, Hoon Jang ; Do, Sik Min. / Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells. In: Experimental and Molecular Medicine. 2009 ; Vol. 41, No. 9. pp. 678-685.
@article{ede70631847f49c8a49fc411b0fbca05,
title = "Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells",
abstract = "In spite of the importance of phospholipase D (PLD) in cell proliferation and tumorigenesis, little is known about the molecules regulating PLD expression. Thus, identification of small molecules inhibiting PLD expression would be an important advance for PLD-mediated physiology. We examined one such here, denoted {"}Triptolide{"}, which was identified in a chemical screen for inhibitors of PLD expression using cell assay system based on measurement of PLD promoter activity. Triptolide significantly suppressed the expression of both PLD1 and PLD2 with sub-μM potency in MDA-MB-231 breast cancer cells as analyzed by promoter assay and RT-PCR. Moreover, triptolide abolished the protein level of PLD in a time and dose-dependent manner. Triptolide-induced PLD1 downregulation was also observed in all the cancer cells examined, suggesting a general phenomenon detected in various cancer cells. Decrease of PLD expression by triptolide suppressed both basal and PMA-induced PLD activity. In addition, triptolide inhibited activation of NFκB which increased PLD1 expression. Ultimately, downregulation of PLD by triptolide inhibited proliferation of breast cancer cells. Taken together, we demonstrate that triptolide suppresses the expression of PLD via inhibition of NFκB activation and then decreases cell proliferation.",
author = "Dong, {Woo Kang} and Ji, {Young Lee} and Oh, {Deuk Hee} and Seon, {Yang Park} and Tae, {Min Woo} and Mi, {Kyoung Kim} and Mi, {Hee Park} and Young, {Hoon Jang} and Do, {Sik Min}",
year = "2009",
month = "9",
day = "30",
doi = "10.3858/emm.2009.41.9.074",
language = "English",
volume = "41",
pages = "678--685",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "9",

}

Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells. / Dong, Woo Kang; Ji, Young Lee; Oh, Deuk Hee; Seon, Yang Park; Tae, Min Woo; Mi, Kyoung Kim; Mi, Hee Park; Young, Hoon Jang; Do, Sik Min.

In: Experimental and Molecular Medicine, Vol. 41, No. 9, 30.09.2009, p. 678-685.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells

AU - Dong, Woo Kang

AU - Ji, Young Lee

AU - Oh, Deuk Hee

AU - Seon, Yang Park

AU - Tae, Min Woo

AU - Mi, Kyoung Kim

AU - Mi, Hee Park

AU - Young, Hoon Jang

AU - Do, Sik Min

PY - 2009/9/30

Y1 - 2009/9/30

N2 - In spite of the importance of phospholipase D (PLD) in cell proliferation and tumorigenesis, little is known about the molecules regulating PLD expression. Thus, identification of small molecules inhibiting PLD expression would be an important advance for PLD-mediated physiology. We examined one such here, denoted "Triptolide", which was identified in a chemical screen for inhibitors of PLD expression using cell assay system based on measurement of PLD promoter activity. Triptolide significantly suppressed the expression of both PLD1 and PLD2 with sub-μM potency in MDA-MB-231 breast cancer cells as analyzed by promoter assay and RT-PCR. Moreover, triptolide abolished the protein level of PLD in a time and dose-dependent manner. Triptolide-induced PLD1 downregulation was also observed in all the cancer cells examined, suggesting a general phenomenon detected in various cancer cells. Decrease of PLD expression by triptolide suppressed both basal and PMA-induced PLD activity. In addition, triptolide inhibited activation of NFκB which increased PLD1 expression. Ultimately, downregulation of PLD by triptolide inhibited proliferation of breast cancer cells. Taken together, we demonstrate that triptolide suppresses the expression of PLD via inhibition of NFκB activation and then decreases cell proliferation.

AB - In spite of the importance of phospholipase D (PLD) in cell proliferation and tumorigenesis, little is known about the molecules regulating PLD expression. Thus, identification of small molecules inhibiting PLD expression would be an important advance for PLD-mediated physiology. We examined one such here, denoted "Triptolide", which was identified in a chemical screen for inhibitors of PLD expression using cell assay system based on measurement of PLD promoter activity. Triptolide significantly suppressed the expression of both PLD1 and PLD2 with sub-μM potency in MDA-MB-231 breast cancer cells as analyzed by promoter assay and RT-PCR. Moreover, triptolide abolished the protein level of PLD in a time and dose-dependent manner. Triptolide-induced PLD1 downregulation was also observed in all the cancer cells examined, suggesting a general phenomenon detected in various cancer cells. Decrease of PLD expression by triptolide suppressed both basal and PMA-induced PLD activity. In addition, triptolide inhibited activation of NFκB which increased PLD1 expression. Ultimately, downregulation of PLD by triptolide inhibited proliferation of breast cancer cells. Taken together, we demonstrate that triptolide suppresses the expression of PLD via inhibition of NFκB activation and then decreases cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=70349454064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349454064&partnerID=8YFLogxK

U2 - 10.3858/emm.2009.41.9.074

DO - 10.3858/emm.2009.41.9.074

M3 - Article

C2 - 19478552

AN - SCOPUS:70349454064

VL - 41

SP - 678

EP - 685

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 9

ER -